Table 2 Kidney-related Outcomes
Characteristics | TSC-AML Patient Age < = 18 (N = 31) | TSC-AML Patient Age > 18 (N = 79) | Total TSC-AML Patients (N = 110) |
|---|---|---|---|
Embolization (e.g., for kidney lesions) | 2 (7%) | 23 (29%) | 25 (23%) |
Nephrectomy (kidney removal) | 2 (7%) | 12 (15%) | 14 (13%) |
Kidney transplant | 0 (0%) | 13 (17%) | 13 (12%) |
Had impaired kidney function | 4 (13%) | 39 (49%) | 43 (39%) |
Had high blood pressure/hypertension | 3 (10%) | 35 (44%) | 38 (35%) |
Had chronic kidney disease | 4 (13%) | 30 (38%) | 34 (31%) |
Had kidney failure | 0 (0%) | 23 (29%) | 23 (21%) |
On dialysis | 0 (0%) | 17 (22%) | 17 (16%) |
AML tumor involvement | |||
 In both kidneys | 26 (84%) | 60 (76%) | 86 (78%) |
 Only in one kidney | 5 (16%) | 19 (24%) | 24 (22%) |
  Multiple tumors | 3 (60%) | 4 (21%) | 7 (29%) |
  Only one tumor | 2 (40%) | 15 (79%) | 17 (71%) |